Krishna Vaddi
2022
In 2022, Krishna Vaddi earned a total compensation of $3.3M as Chief Executive Officer at Prelude Therapeutics, a 53% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $238,425 |
---|---|
Option Awards | $2,498,244 |
Salary | $558,333 |
Other | $9,150 |
Total | $3,304,152 |
Vaddi received $2.5M in option awards, accounting for 76% of the total pay in 2022.
Vaddi also received $238.4K in non-equity incentive plan, $558.3K in salary and $9.2K in other compensation.
Rankings
In 2022, Krishna Vaddi's compensation ranked 1,096th out of 5,753 executives tracked by ExecPay. In other words, Vaddi earned more than 80.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,096 | 81st |
Manufacturing | 523 | 83rd |
Chemicals And Allied Products | 191 | 87th |
Drugs | 172 | 87th |
Pharmaceutical Preparations | 130 | 87th |
Vaddi's colleagues
We found two more compensation records of executives who worked with Krishna Vaddi at Prelude Therapeutics in 2022.